​

Connect Biopharma Ownership | Who Owns Connect Biopharma?

OverviewForecastFinancialsChart

Connect Biopharma Ownership Summary

Connect Biopharma is owned by 5.34% institutional investors, 41.16% insiders, and 53.50% retail investors. Renaissance is the largest institutional shareholder, holding 385.43% of CNTB shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.05% of its assets in Connect Biopharma shares.

CNTB Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockConnect Biopharma5.34%41.16%53.50%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Renaissance212.30K385.43%$322.70K
Blackrock103.89K188.61%$157.91K
Geode capital management27.96K50.76%$42.50K
Rhumbline advisers9.50K17.25%$14.44K
Bml capital management2.04M3.71%$3.11M
Ubs oconnor510.70K0.93%$776.27K
Jpmorgan chase121.000.22%$184.00
Keudell/morrison wealth management32.20K0.06%$48.94K
Commonwealth equity services20.00K0.04%$30.00K
Royal bank of canada12.70K0.02%$19.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management2.04M2.22%$3.11M
Ubs oconnor510.70K0.05%$776.27K
Keudell/morrison wealth management32.20K0.01%$48.94K
Renaissance212.30K0.00%$322.70K
Rhumbline advisers9.50K-$14.44K
Jpmorgan chase121.00-$184.00
Royal bank of canada12.70K-$19.00K
Qube research---
Geode capital management27.96K-$42.50K
Morgan stanley3.57K-$5.42K

Top Buyers

HolderShares% AssetsChange
Royal bank of canada12.70K-12.70K
Keudell/morrison wealth management32.20K0.01%12.50K
Morgan stanley3.57K-3.57K
Commonwealth equity services20.00K--
Ubs oconnor510.70K0.05%-

Top Sellers

HolderShares% AssetsChange
Blackrock103.89K--936.18K
Renaissance212.30K0.00%-27.60K
Bml capital management2.04M2.22%-18.09K
Two sigma investments, lp---10.80K
Rhumbline advisers9.50K--7.02K

New Positions

HolderShares% AssetsChangeValue
Morgan stanley3.57K-3.57K$5.42K

Sold Out

HolderChange
Qube research-46.00
Two sigma investments, lp-10.80K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202411-8.33%2,944,726-1.06%518.33%566.67%1-75.00%
Jun 30, 2024129.09%2,976,236-24.60%510.51%350.00%4-
Mar 31, 202411-26.67%3,947,159-44.56%74.29%2-71.43%4-33.33%
Dec 31, 20231515.38%7,119,105-29.36%123.86%7133.33%6200.00%
Sep 30, 202313-13.33%10,078,544-2.70%185.17%3-25.00%2-60.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index27.96K0.05%-

CNTB Ownership FAQ

Who Owns Connect Biopharma?

Connect Biopharma shareholders are primarily institutional investors at 5.34%, followed by 41.16% insiders and 53.50% retail investors. The average institutional ownership in Connect Biopharma's industry, Biotech Stocks , is 47.04%, which Connect Biopharma falls below.

Who owns the most shares of Connect Biopharma?

Connect Biopharma’s largest shareholders are Renaissance (212.3K shares, 385.43%), Blackrock (103.89K shares, 188.61%), and Geode capital management (27.96K shares, 50.76%). Together, they hold 624.80% of Connect Biopharma’s total shares outstanding.

Does Blackrock own Connect Biopharma?

Yes, BlackRock owns 188.61% of Connect Biopharma, totaling 103.89K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 157.91K$. In the last quarter, BlackRock decreased its holdings by -936K shares, a -90.01% change.

Who is Connect Biopharma’s biggest shareholder by percentage of total assets invested?

Bml capital management is Connect Biopharma’s biggest shareholder by percentage of total assets invested, with 2.22% of its assets in 2.04M Connect Biopharma shares, valued at 3.11M$.

Who is the top mutual fund holder of Connect Biopharma shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Connect Biopharma shares, with 0.05% of its total shares outstanding invested in 27.96K Connect Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools